[PDF][PDF] Rivaroxaban-Excipient Compatibility Studies for Advanced Drug delivery Systems Development

MM Alburyhi, MA Hamidaddin, MA Noman… - European Journal of …, 2024 - researchgate.net
The main objective of the present study was to the preformulation studies were performed to
know the physicochemical and mechanical properties of Rivaroxaban for formulation …

[PDF][PDF] Rosuvastatin-Excipient Compatibility Studies for Advanced Drug delivery Systems Development

MM Alburyhi, MA Noman… - World Journal …, 2024 - wjpr.s3.ap-south-1.amazonaws.com
The safety, efficacy, quality and stability of a formulation are major concepts of any API
development process. In API development process, a detailed characterization of the API …

[PDF][PDF] Lisinopril-Excipient Compatibility Studies for Advanced Drug delivery Systems Development

MM Alburyhi, MA Noman, AA Saif… - World Journal of …, 2024 - researchgate.net
The safety, efficacy, quality and stability of a formulation are major concepts of any API
development process. In API development process, a detailed characterization of the API …

[PDF][PDF] Drotaverine-Excipient Compatibility Studies for Advanced Drug delivery Systems Development

MA Al-Ghorafi, MM Alburyhi, AA Saif… - World Journal of …, 2024 - researchgate.net
WORLD JOURNAL OF PHARMACEUTICAL RESEARCH Page 1 Alburyhi et al. World Journal of
Pharmaceutical Research www.wjpr.net │ Vol 13, Issue 18, 2024. │ ISO 9001:2015 Certified …

[PDF][PDF] Famotidine-Excipient Compatibility Studies for Advanced Drug delivery Systems Development

AA Saif, MM Alburyhi, MA Noman… - World Journal of …, 2024 - researchgate.net
Various scientific and technological advancements have been made in the development of
oral drug delivery systems. Orodispersible tablets dissolve rapidly and show higher …

[PDF][PDF] Ticagrelor-Excipient Compatibility Studies for Advanced Drug delivery Systems Development

MM Alburyhi, AA Saif, MA Noman - World Journal of Pharmacy …, 2024 - researchgate.net
Ticagrelor is one of the most recent antiplatelet agents used to inhibit platelet aggregation
via blocking the Adenosine diphosphate (ADP) receptors of the subtype P2Y12, it used in …

[HTML][HTML] The prognostic role of high-sensitivity C-reactive protein in patients with acute myocardial infarction

EA Polyakova, EN Mikhaylov - Journal of Geriatric Cardiology …, 2020 - ncbi.nlm.nih.gov
Inflammation is one of the main mechanisms in the pathogenesis of atherosclerosis, and the
interest to the evaluation of inflammatory biomarkers in coronary artery disease (CAD) has …

[PDF][PDF] Simvastatin-Excipient Compatibility Studies for Advanced Drug delivery Systems Development

MM Alburyhi, AA Saif… - World Journal …, 2024 - wjpr.s3.ap-south-1.amazonaws.com
Simvastatin is a lipid lowering drug which is used to lower the risk of cardiovascular disease
and manage abnormal lipid levels by inhibiting the endogenous production of cholesterol …

[PDF][PDF] Furosemide-Excipient Compatibility Studies for Advanced Drug delivery Systems Development

MM Alburyhi, YA Salim, AA Saif… - World Journal of …, 2024 - researchgate.net
Furosemide is a potent loop diuretic that acts on the kidneys to ultimately increase water loss
from the body. It is an anthranilic acid derivative. Furosemide is used for edema secondary …

[PDF][PDF] Bisoprolol-Excipient Compatibility Studies for Advanced Drug delivery Systems Development

MM Alburyhi, AA Saif, MA Noman… - World Journal of …, 2024 - pharmaexcipients.com
Fast dissolving drug delivery systems offers a solution for pediatric, geriatric, mentally ill
people and those patients having difficulty in swallowing tablets or capsules. In the present …